Y-Intercept (HK) Portfolio holdings
Y-Intercept is a Hong Kong hedge fund firm that trades with computer-driven models, backed by Schonfeld Strategic Advisors. Its main strategy is statistical arbitrage across global stocks and related instruments. For years it managed money only for Schonfeld, until it opened its first fund to outside investors in 2025. That fund also adds macro strategies, so the firm can trade equities, interest rates, currencies and commodities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allstate
ALL
|
+$66.6M |
| 2 |
TSMC
TSM
|
+$34.9M |
| 3 |
Shopify
SHOP
|
+$29.2M |
| 4 |
Bank of America
BAC
|
+$28.4M |
| 5 |
Aon
AON
|
+$27.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$49.6M |
| 2 |
Boston Scientific
BSX
|
+$46M |
| 3 |
Microsoft
MSFT
|
+$44.5M |
| 4 |
Salesforce
CRM
|
+$37.3M |
| 5 |
Cognizant
CTSH
|
+$34.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 15.64% |
| 3 | Industrials | 12.53% |
| 4 | Healthcare | 11.61% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1476
StepStone Group
STEP
$4.11B
| $210K | ﹤0.01% |
4,829
-80,650
| -94% | -$3.76M |
2026 Q2
1 quarter
|
|
1477
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.8B
| $208K | ﹤0.01% |
+3,379
| New | +$214K |
2026 Q3
0 quarters
|
|
1478
Standex International
SXI
$3B
| $208K | ﹤0.01% |
+763
| New | +$228K |
2026 Q3
0 quarters
|
|
1479
Pacer Data and Digital Revolution ETF
TRFK
$950M
| $206K | ﹤0.01% |
+2,046
| New | +$195K |
2026 Q3
0 quarters
|
|
1480
InnovAge Holding
INNV
$1.26B
| $206K | ﹤0.01% |
+23,361
| New | +$255K |
2026 Q3
0 quarters
|
|
1481
CNX Resources
CNX
$5.28B
| $205K | ﹤0.01% |
6,574
-1,463
| -18% | -$50.7K |
2025 Q4
3 quarters
|
|
1482
Chagee Holdings Ltd
CHA
$2.37B
| $205K | ﹤0.01% |
+17,490
| New | +$197K |
2026 Q3
0 quarters
|
|
1483
Diebold Nixdorf
DBD
$1.92B
| $204K | ﹤0.01% |
+3,336
| New | +$245K |
2026 Q3
0 quarters
|
|
1484
Distribution Solutions Group
DSGR
$1.62B
| $202K | ﹤0.01% |
+5,800
| New | +$195K |
2026 Q3
0 quarters
|
|
1485
Dorian LPG
LPG
$1.97B
| $201K | ﹤0.01% |
3,655
-72,138
| -95% | -$3.46M |
2025 Q3
4 quarters
|
|
1486
State Street SPDR Portfolio High Yield Bond Index ETF
SPHY
$11.9B
| $201K | ﹤0.01% |
+8,883
| New | +$206K |
2026 Q3
0 quarters
|
|
1487
Descartes Systems
DSGX
$8.09B
| $201K | ﹤0.01% |
2,480
-4,986
| -67% | -$380K |
2025 Q3
4 quarters
|
|
1488
Arbor Realty Trust
ABR
$274M
| $180K | ﹤0.01% |
+46,554
| New | +$229K |
2026 Q3
0 quarters
|
|
1489
Kayne Anderson BDC
KBDC
$848M
| $169K | ﹤0.01% |
+13,467
| New | +$181K |
2026 Q3
0 quarters
|
|
1490
Kyverna Therapeutics
KYTX
$314M
| $169K | ﹤0.01% |
24,811
-217,576
| -90% | -$1.72M |
2026 Q1
2 quarters
|
|
1491
Eikon Therapeutics
EIKN
$333M
| $163K | ﹤0.01% |
+20,297
| New | +$204K |
2026 Q3
0 quarters
|
|
1492
DoubleVerify
DV
$2.12B
| $161K | ﹤0.01% |
+11,919
| New | +$150K |
2026 Q3
0 quarters
|
|
1493
Lifestance Health
LFST
$5.53B
| $160K | ﹤0.01% |
+13,307
| New | +$157K |
2026 Q3
0 quarters
|
|
1494
Zura Bio
ZURA
$139M
| $160K | ﹤0.01% |
+38,448
| New | +$205K |
2026 Q3
0 quarters
|
|
1495
BridgeBio Oncology
BBOT
$185M
| $159K | ﹤0.01% |
+38,846
| New | +$302K |
2026 Q3
0 quarters
|
|
1496
XPeng
XPEV
$9.6B
| $153K | ﹤0.01% |
+16,030
| New | +$190K |
2026 Q3
0 quarters
|
|
1497
TAL Education Group
TAL
$5.59B
| $153K | ﹤0.01% |
12,647
-225,304
| -95% | -$2.57M |
2026 Q2
1 quarter
|
|
1498
Alphatec Holdings
ATEC
$1.06B
| $151K | ﹤0.01% |
14,652
-130,401
| -90% | -$1.24M |
2025 Q3
4 quarters
|
|
1499
Stewards, Inc. Common Stock
SWRD
$526M
| $147K | ﹤0.01% |
+60,583
| New | +$142K |
2026 Q3
0 quarters
|
|
1500
Avita Medical
RCEL
$542M
| $143K | ﹤0.01% |
+12,203
| New | +$96.7K |
2026 Q3
0 quarters
|
|
Similar funds
Y-Intercept (HK)'s Q3 2026 Portfolio in Review
As of Q3 2026, Y-Intercept (HK) held 2,238 positions worth $4.52B, down 10% from $5.05B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Y-Intercept (HK) withdrew a net $314M in Q3 2026, closing 706 positions and reducing 464 holdings. Its most notable exit was Microsoft, an estimated $44.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
Against the trend, Y-Intercept (HK) opened a new position in Allstate worth $58.3M.
- Y-Intercept (HK)'s largest Q3 2026 buy was Allstate: 262,728 shares worth $58.3M.
- Y-Intercept (HK) added most to TSMC in Q3 2026, an estimated $34.9M increase.
- Y-Intercept (HK)'s biggest Q3 2026 reduction was Amazon, cutting an estimated $49.6M.
- Y-Intercept (HK) fully exited Microsoft in Q3 2026, selling an estimated $44.5M.
- Y-Intercept (HK)'s ten largest holdings make up 8.2% of its $4.52B portfolio in Q3 2026.
- Y-Intercept (HK) opened 587 new positions and closed 706 in Q3 2026.
- Y-Intercept (HK)'s portfolio value fell 10% quarter-over-quarter to $4.52B.
Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.